PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-05-15

Date Title Company
15-May-2025 CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE CureVac
15-May-2025 Bionxt Solutions Provides Bi-Weekly MCTO Status Report ACCESS Newswire
15-May-2025 Lifeloc Reports First Quarter 2025 Results ACCESS Newswire
15-May-2025 CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE ACCESS Newswire
15-May-2025 Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth ACCESS Newswire
15-May-2025 Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year ACCESS Newswire
15-May-2025 Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli) Viromed Medical AG
15-May-2025 Applied DNA Reports Second Quarter Fiscal 2025 Financial Results ACCESS Newswire
15-May-2025 Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial Affluent Medical SA
15-May-2025 Jaguar Health Reports First Quarter 2025 Financials ACCESS Newswire
15-May-2025 MAQUET Medical Systems AG submits squeeze-out request to Pulsion Medical Systems SE Pulsion Medical Systems SE
15-May-2025 Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board Heidelberg Pharma AG
15-May-2025 Glidewell Launches SimpliOne(TM) Design Service ACCESS Newswire
15-May-2025 Introducing Glidewell TV: The Dental Streaming Network ACCESS Newswire
15-May-2025 Understanding The Growth Of The Cancer Profiling Market By 2035 Market Business Insights
15-May-2025 Labviva Announces Global Expansion, Appoints General Manager of Europe Labviva
15-May-2025 CNX Therapeutics to accelerate European growth strategy with Inflexion's £2.3bn Continuation Fund CNX Therapeutics
15-May-2025 Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 Heidelberg Pharma
15-May-2025 LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% LEO PHARMA
15-May-2025 Bulletin from the Annual General Meeting in Cantargia AB ACCESS Newswire